Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2009 - 2026)

Dr Reddys Laboratories has reported Total Non-Current Liabilities for 18 years, with the latest figure at $1.3 million in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 34.35% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $1.3 million, a 34.35% decrease from a year earlier, with the FY2026 full-year figure at $1.0 million, down 50.0% from the prior year.
• Total Non-Current Liabilities was $1.3 million for Q2 2026 at Dr Reddys Laboratories, up from $1.2 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $2.0 million in Q3 2025, with the low at $652223.7 in Q3 2022.
• Average Total Non-Current Liabilities over 5 years is $1.1 million, with a median of $746290.9 recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities jumped 168.45% in 2025, then sank 34.35% in 2026.
• Over 5 years, Total Non-Current Liabilities stood at $694255.8 in 2022, then grew by 5.52% to $732603.7 in 2023, then soared by 144.12% to $1.8 million in 2024, then sank by 34.07% to $1.2 million in 2025, then gained by 9.29% to $1.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $1.3 million (Q2 2026), $1.2 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.